Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01F
- Chemical subgroupL01FG
- Chemical substanceL01FG01Bevacizumab
S01LA08
Where it is registered
Each register with its number of medicines and a few of them.
European Union
EMA · 16 medicines
- AbevmyBiosimilar Collaborations Ireland Limited
- AlymsysMabxience Research SL
- AvastinRoche Registration GmbH
- AvziviFGK Representative Service GmbH
Canada
Health Canada · 15 medicines



